HK Stock MarketDetailed Quotes

02126 JW THERAP-B

Watchlist
  • 1.580
  • +0.050+3.27%
Market Closed May 2 16:08 CST
657.45MMarket Cap-1.03P/E (TTM)

JW THERAP-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
-8.99%158.22M
-1.05%86.82M
19.32%173.86M
32.93%87.74M
373.10%145.7M
--66.01M
--30.8M
----
----
----
Operating income
-8.99%158.22M
-1.05%86.82M
19.32%173.86M
32.93%87.74M
373.10%145.7M
66.01M
30.8M
Cost of sales
5.53%-80.9M
-0.33%-43.07M
1.51%-85.64M
-0.12%-42.93M
-299.71%-86.95M
---42.88M
---21.75M
----
----
----
Operating expenses
5.53%-80.9M
-0.33%-43.07M
1.51%-85.64M
-0.12%-42.93M
-299.71%-86.95M
-42.88M
-21.75M
Gross profit
-12.36%77.32M
-2.38%43.75M
50.14%88.22M
93.74%44.81M
549.60%58.76M
23.13M
9.05M
Selling expenses
-24.04%-140.41M
-26.60%-76.17M
40.70%-113.2M
28.75%-60.17M
-11.80%-190.88M
-82.88%-84.45M
-1,186.80%-170.73M
---46.18M
---13.27M
----
Administrative expenses
14.27%-120.07M
24.73%-59.23M
22.09%-140.05M
13.45%-78.69M
10.80%-179.76M
13.49%-90.92M
12.87%-201.52M
-29.74%-105.1M
-217.31%-231.29M
-216.98%-81.01M
Research and development expenses
31.58%-282.99M
30.26%-151.01M
-1.42%-413.62M
-10.54%-216.53M
1.59%-407.82M
-5.59%-195.89M
-84.00%-414.4M
-125.50%-185.51M
-65.47%-225.22M
-51.63%-82.27M
Special items of operating profit
33.32%-140.68M
93.89%-4.85M
-54.92%-210.97M
5.36%-79.34M
-835.36%-136.18M
-2,713.15%-83.83M
-36.01%18.52M
-35.35%3.21M
570.19%28.94M
1,793.52%4.96M
Operating profit
23.15%-606.84M
36.52%-247.51M
7.74%-789.61M
9.73%-389.92M
-12.75%-855.88M
-29.49%-431.96M
-72.19%-759.08M
-110.71%-333.58M
-115.38%-440.84M
-97.63%-158.31M
Financing income
-16.44%28.43M
-11.86%13.3M
105.78%34.03M
179.41%15.09M
99.31%16.54M
179.21%5.4M
141.09%8.3M
1,434.92%1.93M
89.07%3.44M
-18.71%126K
Financing cost
1.57%-12.22M
-8.42%-6.05M
-82.92%-12.42M
-106.85%-5.58M
-152.12%-6.79M
-402.61%-2.7M
-249.61%-2.69M
-85.17%-537K
43.01%-770K
67.19%-290K
Special items of earning before tax
----
----
----
----
----
----
104.17%51.15M
110.47%51.49M
-185.67%-1.23B
-77.43%-491.55M
Earning before tax
23.10%-590.62M
36.84%-240.27M
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
After-tax profit from continuing operations
23.10%-590.62M
36.84%-240.27M
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
Earning after tax
23.10%-590.62M
36.84%-240.27M
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
Profit attributable to shareholders
23.10%-590.62M
36.84%-240.27M
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
Basic earnings per share
23.53%-1.43
37.63%-0.58
9.22%-1.87
11.43%-0.93
-17.05%-2.06
-47.89%-1.05
86.04%-1.76
92.87%-0.71
-29.47%-12.61
-80.76%-9.96
Diluted earnings per share
23.53%-1.43
37.63%-0.58
9.22%-1.87
11.43%-0.93
-17.05%-2.06
-47.89%-1.05
86.04%-1.76
92.87%-0.71
-29.47%-12.61
-80.76%-9.96
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover -8.99%158.22M-1.05%86.82M19.32%173.86M32.93%87.74M373.10%145.7M--66.01M--30.8M------------
Operating income -8.99%158.22M-1.05%86.82M19.32%173.86M32.93%87.74M373.10%145.7M66.01M30.8M
Cost of sales 5.53%-80.9M-0.33%-43.07M1.51%-85.64M-0.12%-42.93M-299.71%-86.95M---42.88M---21.75M------------
Operating expenses 5.53%-80.9M-0.33%-43.07M1.51%-85.64M-0.12%-42.93M-299.71%-86.95M-42.88M-21.75M
Gross profit -12.36%77.32M-2.38%43.75M50.14%88.22M93.74%44.81M549.60%58.76M23.13M9.05M
Selling expenses -24.04%-140.41M-26.60%-76.17M40.70%-113.2M28.75%-60.17M-11.80%-190.88M-82.88%-84.45M-1,186.80%-170.73M---46.18M---13.27M----
Administrative expenses 14.27%-120.07M24.73%-59.23M22.09%-140.05M13.45%-78.69M10.80%-179.76M13.49%-90.92M12.87%-201.52M-29.74%-105.1M-217.31%-231.29M-216.98%-81.01M
Research and development expenses 31.58%-282.99M30.26%-151.01M-1.42%-413.62M-10.54%-216.53M1.59%-407.82M-5.59%-195.89M-84.00%-414.4M-125.50%-185.51M-65.47%-225.22M-51.63%-82.27M
Special items of operating profit 33.32%-140.68M93.89%-4.85M-54.92%-210.97M5.36%-79.34M-835.36%-136.18M-2,713.15%-83.83M-36.01%18.52M-35.35%3.21M570.19%28.94M1,793.52%4.96M
Operating profit 23.15%-606.84M36.52%-247.51M7.74%-789.61M9.73%-389.92M-12.75%-855.88M-29.49%-431.96M-72.19%-759.08M-110.71%-333.58M-115.38%-440.84M-97.63%-158.31M
Financing income -16.44%28.43M-11.86%13.3M105.78%34.03M179.41%15.09M99.31%16.54M179.21%5.4M141.09%8.3M1,434.92%1.93M89.07%3.44M-18.71%126K
Financing cost 1.57%-12.22M-8.42%-6.05M-82.92%-12.42M-106.85%-5.58M-152.12%-6.79M-402.61%-2.7M-249.61%-2.69M-85.17%-537K43.01%-770K67.19%-290K
Special items of earning before tax ------------------------104.17%51.15M110.47%51.49M-185.67%-1.23B-77.43%-491.55M
Earning before tax 23.10%-590.62M36.84%-240.27M9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M
After-tax profit from continuing operations 23.10%-590.62M36.84%-240.27M9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M
Earning after tax 23.10%-590.62M36.84%-240.27M9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M
Profit attributable to shareholders 23.10%-590.62M36.84%-240.27M9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M
Basic earnings per share 23.53%-1.4337.63%-0.589.22%-1.8711.43%-0.93-17.05%-2.06-47.89%-1.0586.04%-1.7692.87%-0.71-29.47%-12.61-80.76%-9.96
Diluted earnings per share 23.53%-1.4337.63%-0.589.22%-1.8711.43%-0.93-17.05%-2.06-47.89%-1.0586.04%-1.7692.87%-0.71-29.47%-12.61-80.76%-9.96
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte Guan Huang Chen Fang Certified Public Accountants--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More